1	Charney DS, Heninger GR, Breier A:Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41: 751-763, 1984
	2	Charney DS, Heninger GR : Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 43 : 1042-1054, 1986
	3	Mongean R, Weiss M, de Montigny C et al:Effect of acute. short-and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons. Neuropharmacology 37 : 905-918, 1998
	4	鉾之原忠実,川崎 幸,望月大介:新規抗うつ薬ミルナシプランの反復投与による5-HT1A受容体機能への影響.(1)前シナプス神経(背側縫線核)での検討.旭化成社内資料.
	5	Moret C, Briley M : Effect of milnacipran and desipramine on noradrenergic alpha 2-autoreceptor sensitivity. Prog Neuropsychopharmacol Biol Psychiatry 18 : 1063-1072, 1994
	6	貝谷久宣:パニック障害の精神薬理学.最新脳と神経科学シリーズ4,最新の伝達物質-受容体の分子機構と関連神経疾患.(高橋徹,設楽信行,清水輝夫編)メジカルビュー,東京,1996,pp192-203
	7	Moret C, Briley M:Effects of milnacipran and pindolol on extracellular noradrenaline and serotonin levels in guinea pig hypothalamus. J Neurochem 69:815-822, 1997
	8	Assie MB, Charveron M, Palmier C et al:Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat. Neuropharmacology 31:149-155, 1992
	9	Bel N, Artigas F:Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats. Neuropsychopharmacology 21:745-754, 1999
	10	Klein DF, Fink M:Psychiatric reaction patterns to imipramine. Am J Psychiatry 119:432-438, 1962
	11	Klein DF:Delineation of two drugs responsive anxiety syndromes. Psychopharmacologia 5:397-408, 1964
	12	Sheehan DV. Ballenger J, Jacobsen G:Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. Arch Gen Psychiatry 37:51-59, 1980
	13	Kalus 0, Asnis GM, Rubinson E et al Desipramine treatment in panic disorder. J Affect Disord 21:239-244, 1991
	14	Lydiard RB, Morton WA. Emmanuel NP et al:Preliminary report placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol Bull 29:183-188, 1993
	15	Sasson Y, Iancu I, Fux M et al:A doubleblind crossover comparison of clomipramine and desipramine in the treatment of panic disorder. Eur Neuropsychopharmacol 9:191-196, 1999
	16	Versiani MV, Montgomery SA, Stahl SM et al:Effect of the novel selective norepinephrine reuptake inhibitor reboxetine on anxiety. American Psychiatric Association, 2001 Annual Meeting. New Orleans, LA May 9, 2001
	17	Den Boer JA, Westenberg HG:Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder a double blind comparative study with fluvoxamine and maprotiline. Int Clin Psychopharmacol 3:59-74, 1988
	18	Nyback HV, Walters JR. Aghajanian GK et al:Tricyclic antidepressants effects on the firing rate of brain noradrenergic neurons. Eur J Pharmacol 32:302-312, 1975
	19	Charney DS, Heninger GR:Noradrenergic function and the mechanism of action of antianxiety treatment. �U:The effect of long-term imipramine treatment. Arch Gen Psychiatry 42:473-481, 1985
	20	Albus M, Zahn TP, Breier A:Anxiogenic properties of yohimbine. �U. Influence of experimental set and setting. Eur Arch Psychiatry Clin Neurosci 241:345-351, 1992
	21	Lecrubier Y, Bakker A. Dunbar G et al:A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Acta Psychiatr Scand 95:145-152, 1997
	22	Modigh K, Westberg P, Eriksson E:Superiority of clomipramine over irnipramine in the treatment of panic disorder a placebo-controlled trial. J Clin Psychopharmacol 12:251-261, 1992
	23	Ballenger JC:Selective serotonin reuptake inhibitors (SSRI) in panic disorder, 笠茂公弘訳,第11章,パニック障害におけるSSRI,編訳:久保木富房,井上雄一,パニック障害病態から治療まで,日本評論社,東京,2001 pp203-229
	24	Gorman JM:The use of newer antidepressants for panic disorder. J Clin Psychiatry 58 (Suppl 14):54-58, 1997
	25	Ninan PT:Use of venlafaxine in other psychiatric disorders. Depress Anxiety 12 (Suppl 1):90-94, 2000
	26	Geracioti TD Jr Venlafaxine treatment of panic disorder:a case series. J Clin Psychiatry 56:408-410, 1995
	27	Papp LA. Sinha SS, Martinez JM et al:Low-dose venlafaxine treatment in panic disorder. Psychopharmacol Bull 34:207-209, 1998
	28	Pollack MH, Worthington JJ 3rd, Otto MW et al:Venlafaxine for panic disorder results from a double-blind, placebo-controlled study. Psychopharmacol Bull 32:667-670, 1996
	29	Ansseau M, von Frenckell R, Serre C:Pilot study of milnacipran in panic disorder. Eur Psychiatry 6:103-105, 1991
	30	Hascoet M, Bourin M, Colombel MC et al:Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacol Biochem Behav 65:339-344, 2000
	31	Hashimoto S. Inoue T, Koyama T:Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats. Psychopharmacology (Berl) 123:182-186, 1996
	32	貝谷久宣,上松正幸:パニック・ディスオーダーの精神薬理学をめぐって.精神医学レビューNo.3 パニック・ディスオーダー 編集高橋 徹,ライフ・サイエンス,東京,1992pp.22-32
	33	Carr DB, Sheehan DV, Surman OS et al:Neuroendocrine correlates of lactate-induced anxiety and their response to chronic aiprazolam therapy. Am J Psychiatry 143:483-494, 1986
	34	貝谷久宣,宮前義和:パニック障害における抑うつ状態,パニック障害研究最前線;貝谷久宣/不安・抑うつ臨床研究会編,日本評論社,東京,2000,pp55-78
	35	貝谷久宣,宮前義和:パニック障害における抑うつ状態一パニック性不安うつ病(2)臨床的特徴,パニック障害症例集;貝谷久宣/不安・抑うつ臨床研究会編,日本評論社,東京,2001,pp149-168
	36	Liebowitz MR. Quitkin FM, Stewart JW et al : Phenelzine v imipramine in atypical depression. A preliminary report. Arch Gen Psychiatry 41 : 669-677, 1984